| Joseph Long Dc Pa | |
|
506 Hospital Drive Mountain Home AR 72653-2913 | |
| (870) 424-5853 | |
| (870) 424-5856 |
| Full Name | Joseph Long Dc Pa |
|---|---|
| Speciality | Clinic/Center |
| Location | 506 Hospital Drive, Mountain Home, Arkansas |
| Authorized Official Name and Position | Joseph G Long (CHIROPRACTOR) |
| Authorized Official Contact | 8704255853 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Long Dc Pa 506 Hospital Drive Mountain Home AR 72653-2913 Ph: (870) 424-5853 | Joseph Long Dc Pa 506 Hospital Drive Mountain Home AR 72653-2913 Ph: (870) 424-5853 |
| NPI Number | 1295991917 |
|---|---|
| Provider Enumeration Date | 08/01/2008 |
| Last Update Date | 10/04/2022 |
| Medicare PECOS PAC ID | 9739342445 |
|---|---|
| Medicare Enrollment ID | O20120516000435 |
News Archive
Uganda this year plans to conduct a survey to determine the prevalence of multi-drug resistant tuberculosis in the country, National Leprosy and TB program manager Francis Adatu said Wednesday, the Monitor reports.
Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The Associated Press: Attorneys for 20 states involved in a challenge to the new health law argued Thursday morning before U.S. District Judge Roger Vinson that it will "expand the government's powers in dangerous and unintended ways." The states were seeking "a summary judgment throwing out the health care law without a full trial. They argue it violates people's rights by forcing them to buy health insurance by 2014 or face penalties."
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
The Associated Press: A new ethics code adopted by leading medical groups on Wednesday is supposed to keep the drug and medical device industry from having too much financial influence over medical practitioners. "It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest — a growing concern as private industry bankrolls a greater share of medical research.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295991917 | NPI | - | NPPES |
| 137621718 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Joseph Gordon Long |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1629085931 PECOS PAC ID: 2264484559 Enrollment ID: I20080723000353 |
News Archive
Uganda this year plans to conduct a survey to determine the prevalence of multi-drug resistant tuberculosis in the country, National Leprosy and TB program manager Francis Adatu said Wednesday, the Monitor reports.
Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The Associated Press: Attorneys for 20 states involved in a challenge to the new health law argued Thursday morning before U.S. District Judge Roger Vinson that it will "expand the government's powers in dangerous and unintended ways." The states were seeking "a summary judgment throwing out the health care law without a full trial. They argue it violates people's rights by forcing them to buy health insurance by 2014 or face penalties."
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
The Associated Press: A new ethics code adopted by leading medical groups on Wednesday is supposed to keep the drug and medical device industry from having too much financial influence over medical practitioners. "It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest — a growing concern as private industry bankrolls a greater share of medical research.
› Verified 1 days ago
News Archive
Uganda this year plans to conduct a survey to determine the prevalence of multi-drug resistant tuberculosis in the country, National Leprosy and TB program manager Francis Adatu said Wednesday, the Monitor reports.
Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, for two B-cell malignancy indications: previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The Associated Press: Attorneys for 20 states involved in a challenge to the new health law argued Thursday morning before U.S. District Judge Roger Vinson that it will "expand the government's powers in dangerous and unintended ways." The states were seeking "a summary judgment throwing out the health care law without a full trial. They argue it violates people's rights by forcing them to buy health insurance by 2014 or face penalties."
Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.
The Associated Press: A new ethics code adopted by leading medical groups on Wednesday is supposed to keep the drug and medical device industry from having too much financial influence over medical practitioners. "It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest — a growing concern as private industry bankrolls a greater share of medical research.
› Verified 1 days ago
Regional Family Medicine Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 630 Burnett Dr, Mountain Home, AR 72653 Phone: 870-425-6971 Fax: 870-508-8900 | |
Vitality Plus Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 501 Hospital Dr, Mountain Home, AR 72653 Phone: 870-580-0283 Fax: 870-580-0297 | |
Yourpersonalmd.com Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 S College St, Suite 3, Mountain Home, AR 72653 Phone: 870-424-9763 Fax: 870-424-9762 | |
Baxter Health Med-peds Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 Medical Plz, Mountain Home, AR 72653 Phone: 870-424-3824 Fax: 870-424-3826 | |
The Relief Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 40 Plaza Way Ste 30, Mountain Home, AR 72653 Phone: 870-492-5012 Fax: 870-492-5009 | |
Mtn Home Medical Group Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 353 East 8th Street, Mountain Home, AR 72653 Phone: 870-425-3125 Fax: 870-424-5059 | |
Brmc Transitional Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 Fax: 870-424-6616 |